Articles tagged with Inflammation
Research suggests that supplementing with short chain fatty acids can improve stroke recovery by reducing inflammation and promoting neuroinflammation. The study found that mice who drank water with added fatty acids experienced better stroke recovery, including reduced motor impairment and increased spine growth.
A new study found that delivering the TB vaccine intravenously dramatically improves its potency, offering nearly full protection against TB in monkeys. The vaccine was highly effective when administered via injection into a vein, reducing bacterial burden by 100,000-fold and inflammation in lungs to near zero.
A study by McMaster University researchers found that levels of NT-proBNP, a common cardiac blood test, can predict cardiac and vascular complications after non-cardiac surgery. The test may help doctors identify patients at risk and inform treatment decisions.
Researchers at Cincinnati Children's Hospital Medical Center discovered a new molecular process in mice that triggers T cell-driven inflammation and causes autoimmune diseases. The study found that interactions between myeloid cells and CD4-positive T cells produce excessive IL-1b, leading to auto-inflammatory diseases.
Researchers at Case Western Reserve University have discovered a crucial connection between interleukin-1α and gut microbiome function in a mouse model of Crohn's disease. Blocking this protein reduces intestinal inflammation severity, with effects comparable to steroids, which are the current gold standard treatment.
A new human autoinflammatory disease called CRIA syndrome has been discovered and identified by an Australian-US research team. The disease is caused by a mutation in the RIPK1 protein, leading to uncontrolled cell death and inflammation.
Researchers found that energy-producing mitochondria in muscles were abnormal and showed signs of oxidative damage, contributing to chronic muscle weakness. The study suggests the need for antioxidant therapies or other treatments to restore mitochondrial health.
A study by Wake Forest School of Medicine identified a dead probiotic strain that reduces age-related leaky gut and inflammation in older mice. The dead probiotic strain, Lactobacillus paracasei D3-5, extended the lifespan of roundworms and improved physical and cognitive functions in mice.
The NeutroCure project focuses on harnessing the potential of reactive oxygen species (ROS) produced by neutrophils to treat inflammatory diseases. By developing safe ROS amplifiers, the consortium aims to selectively target pathogenic inflammation and cancer cells while minimizing damage to healthy tissues.
A new treatment approach for cystic fibrosis may reduce the need for lung transplants and lower mortality rates. Researchers found that a small molecule reduced inflammation and cleared lungs of bacteria in a laboratory model.
Researchers found that mice lacking an inflammation resolution sensor developed spontaneous obesity, heart disease, and shortened lifespan, indicating impaired inflammation resolution. This study sheds light on the sensor's integrative role in managing cardiometabolic health and inflammation-resolution processes.
A study of over 200 patients with bipolar disorder found that high levels of inflammation, as measured by C-reactive protein, were significantly linked to poor cognitive performance. This suggests a potentially modifiable risk factor for cognitive deficits, and highlights the importance of addressing inflammation in treatment.
A study by Yale researchers has found that adipose B cells in belly fat unexpectedly proliferate with aging, contributing to increased inflammation and metabolic decline. The expansion can be reversed by reducing macrophage signals and removing adipose B cells.
Patients with inflammatory bowel disease are more likely to develop Parkinson's disease due to shared underlying inflammation. While the risk is small, early detection and intervention may be crucial in slowing or stopping PD progression.
A six-week treatment with low-dose oral prednisolone substantially improves pain and decreases signs of inflammation in patients with painful hand osteoarthritis. Substantial improvements in pain and function were seen, exceeding effects of currently available therapies.
A large-scale trial found that vitamin D and omega-3 fatty acid supplements had no effect on reducing markers of systemic inflammation in older US adults. However, participants with low initial fish intake saw a decrease in inflammation biomarkers after taking the omega-3 supplement.
Researchers have developed a non-invasive method to visualize kidney disease in live animals using genetically modified mice. They found that a promising chemical found in citrus fruit, G-Hes, reduces inflammation in the kidneys when fed to mice with kidney disease.
Researchers at Washington State University have identified a new therapeutic target for the treatment of gout, a common type of arthritis that causes episodes of painful and stiff joints. Blocking the signaling molecule TAK1 can suppress inflammation caused by gout, according to the study.
A study published in the Journal of Investigative Dermatology found that ketogenic diets heavy in coconut oil and palm oils worsened psoriasiform-like skin inflammation in mice. In contrast, well-balanced ketogenic diets with long-chain triglycerides did not exacerbate skin inflammation.
Researchers discover a new drug that reduces inflammation and improves heart function in genetically inherited heart disease, ACM. The treatment targets the immune system's role in disease progression.
Increased inflammatory activity found in FTD patients, associated with parkinsonism symptoms and rapid disease progression. The study also revealed a low prevalence of cancer among FTD patients, suggesting an overactive immune system may contribute to the disease.
Researchers have identified a new class of therapy for dry eye disease by targeting anti-citrullinated protein autoantibodies (ACPA) with antibody-based eye drops. The treatment has shown statistically significant and clinically meaningful reductions in corneal damage and symptoms in patients with severe dry eye disease.
Researchers found that coffee bean extracts reduced fat-induced inflammation and improved glucose absorption and insulin sensitivity in mice. The compounds protocatechuic acid and gallic acid showed promise as a strategy for preventing obesity-related chronic illnesses.
A randomized clinical trial found that high-dose intravenous vitamin C did not reduce organ failure, inflammation, or vascular injury in patients with sepsis and acute respiratory distress syndrome (ARDS). The study's limitations include underpowered detection of differences and insufficient dosage.
Researchers found that inflammation amplifies neurite growth in neurons involved in thermal sensations, leading to increased pain hypersensitivity. Cav2.2 calcium channel genes play a key role in this process, promoting thermosensitive neuronal activity and sensory nerve outgrowth.
Researchers found that certain flavored e-cigarette flavors, even without nicotine, can exacerbate asthma symptoms and increase tissue scarring. Flavors like Black Licorice and Banana Pudding were particularly problematic.
Researchers discovered LH dipeptide as a potent anti-inflammatory agent that inhibits the secretion of inflammatory cytokines from microglia, reducing brain inflammation and depression symptoms. Consuming foods rich in LH dipeptide may be a safe method for maintaining good mental health.
A plant-based diet has been shown to reduce inflammation and improve symptoms of rheumatoid arthritis through various mechanisms. Studies have found that plant-based diets are low in fat and high in fiber, which can reduce inflammatory markers and promote healthy gut bacteria.
A NIH-funded clinical trial found that methotrexate was more effective than mycophenolate mofetil in controlling inflammation and treatment success for patients with severe forms of uveitis. At six months, 74% of participants in the methotrexate group achieved control compared to 55% in the mycophenolate group.
A study using a blood marker of inflammation found an association between late adolescence inflammation and death among Swedish men up to age 57. The results suggest that chronic inflammation in young adulthood may increase the risk of mortality decades later.
Researchers at Stanford University School of Medicine have found that inflammation in the lungs can wake up a silent genetic defect that causes sudden onset cases of pulmonary hypertension. The study suggests that limiting potential environmental causes of lung inflammation may help prevent the development of the disease.
A Yale-led study reveals that transforming growth factor beta (TGFß) proteins trigger inflammation in endothelial cells, leading to plaque buildup and atherosclerosis. Disrupting TGFβ receptors with RNAi drug reduces inflammation and plaque effectively.
Researchers at University of California San Diego School of Medicine found that removing the enzyme PHLPP1 improves outcomes in a mouse model of sepsis. The study introduces the possibility of inhibiting PHLPP1 as a new treatment for sepsis.
A recent study by Anna M. Gruener et al., published in JAMA Ophthalmology, investigated the association between giant cell arteritis and race. The researchers found a significant association between the disorder and certain ethnic groups, with increased risk observed in African Americans, Hispanics, and individuals of mixed ancestry.
Researchers have identified a molecule called Gas6 that induces macrophages to clean up cellular debris and reduce inflammation. Boosting Gas6 levels in macrophages has been shown to resolve inflammation in mouse models of acute lung injury, holding promise for treating diseases such as heart disease, cancer, and rheumatoid arthritis.
Researchers uncover how cannabis creates potent pain-relieving molecules, targeting inflammation and offering a non-psychoactive alternative to opioids. The discovery enables the development of naturally derived pain treatments with potentially significant benefits for chronic pain sufferers.
A study led by Georgia State University researchers found that fecal miRNA can serve as a tool to assess gut microbiota healthiness and provide early clues to intestinal inflammation in mice. The findings offer new hope for diagnosing chronic gut conditions, such as inflammatory bowel disease.
A study published in Immunity reveals that the synthesis and breakdown of fats play a crucial role in asthma-related inflammation. Researchers used single-cell RNA sequencing to analyze gene expression in immune cells exposed to house dust mites, finding a unique profile of genes linked to fat metabolism.
A study has characterised two distinct populations of gut immune cells, which could help scientists develop treatments targeting inflammation while preserving healthy gut function. The 'good' cell population helps keep the gut lining healthy, while the 'bad' cells cause excessive inflammation and are associated with inflammatory diseases.
Researchers have developed a therapeutic approach that utilizes the endogenous process to turn off inflammation and promote healing in the heart muscle. Annexin A1 protein stimulates new blood vessel formation, increasing blood flow and improving cardiac function.
A recent study by I.R.C.C.S. Neuromed found that obese patients with multiple sclerosis have a greater risk of presenting higher EDSS scores and experiencing increased central inflammation. The research suggests that excessive body weight and altered lipid profiles may be associated with worsened clinical expression of the disease.
Researchers have discovered a molecule called LL-37 that changes cell behavior when infected with bacteria, triggering the production of neutrophils to destroy bacterial threats. The study's findings could lead to new approaches in treating multi-drug resistant infections.
Researchers at Duke-NUS Medical School and NHCS found that deactivating IL11 with therapeutic antibodies reverses inflammation and scarring in patients with non-alcoholic steatohepatitis (NASH). This breakthrough has implications for the development of drugs to treat NASH, a common condition affecting millions worldwide.
Research suggests DGKζ enzyme plays a role in suppressing runaway inflammation in asthma. The enzyme's deletion in mouse T cells led to reduced inflammation and airway hyper-responsiveness, two hallmarks of the disease.
Research suggests that e-cigarettes can diminish the body's ability to fight viruses, including those causing the flu. Cigarettes, on the other hand, appear to increase the risk of becoming sick from the flu due to different factors.
A recent study published in the New England Journal of Medicine found that benralizumab, an asthma drug, was ineffective in reducing exacerbations in patients with moderate to very severe COPD. The study involved over 3,000 patients and showed no significant decrease in COPD exacerbation rates among those receiving benralizumab.
A study using praliciguat to stimulate soluble guanylate cyclase found that it can inhibit inflammation and fibrosis in liver cells, suggesting a potential therapy for nonalcoholic steatohepatitis. The results also indicate that praliciguat may suppress stellate cell fibrotic transformation.
Researchers at University of Queensland discover a way to stop inflammation by inhibiting the inflammasome protein complex. This breakthrough could lead to the design of new anti-inflammatory drugs, informing treatment for chronic inflammatory diseases such as Parkinson's and Alzheimer's.
The Fondren Foundation has pledged $15 million to Houston Methodist to support the development of a comprehensive program addressing complex diseases. The new initiative will focus on advancing research and treatment for gastrointestinal disorders, immunological disorders, and food allergies.
Researchers developed a capsule-shaped photoacoustic imaging endoscope to examine intestinal changes in Crohn's disease. The device can differentiate between inflammatory and fibrotic strictures, allowing for more targeted treatment and potentially reducing adverse effects. This technology could also provide real-time diagnostic inform...
Researchers found that using psychological techniques to communicate periodontal disease risk improved dental hygiene and reduced gum inflammation over a three month period. The study also associated the intervention with improved frequency of interdental cleaning.
A University of Michigan researcher has found that the mechanics producing wheezing and crackling noises with every breath are likely a cause of injury and inflammation. This new understanding could change how lung diseases are treated and represent a paradigm shift in doctor-patient interactions.
The study found that phenolic compounds in purple corn altered the development of fat cells and reduced inflammation and insulin resistance. Different combinations of anthocyanins showed varying effects on these biomarkers.
Researchers have developed a new method for transporting medicine through the body, using a sliding molecule that can jump between polymers to deliver medication to specific organs. Laboratory tests confirm the model's effectiveness in delivering molecules to gel-like materials.
A combination of over-the-counter antioxidants shows promise for mitigating damaging effects of heart failure with preserved ejection fraction. Treatment improved markers of vascular function and inflammation in some patients, suggesting a simple and readily available option to improve vascular health.
A new study reveals that a specific type of immune cell, known as T7 and T8 cells, are responsible for inflammation in eosinophilic esophagitis. The study's findings also raise questions about the safety of a popular dietary supplement called butyrate, which may exacerbate the condition.
A study by WVU researchers found that exposure to white light at night causes multiple poor outcomes in cardiac arrest models, including greater cell death, more aggressive inflammation, and higher mortality rates. In contrast, dim red light had no detrimental effects.
A new drug targeting brain inflammation, MW-151, is ready for its first round of human testing. The medication aims to block 'bad' inflammation that destroys neurons in Alzheimer's disease.
Researchers from VIB have developed a map to model cellular dynamics, highlighting outstanding challenges and pioneering new ways of evaluating computational biology methods. This breakthrough enables the study of individual cell trajectories, revealing complex structures such as cell development in diseases.
Researchers developed a comprehensive map of cell developmental dynamics using AI, enabling the evaluation of computational biology methods. The study highlights outstanding challenges and pioneers new ways to assess trajectory inference methods, leading to improved disease understanding.